Dexcom Inc DXCM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:54 PM EST
353.08quote price arrow up+1.02 (+0.29%)
Volume
51,798
Close
352.06quote price arrow down-12.03 (-3.30%)
Volume
810,033
52 week range
182.07 - 456.23

...

Loading . . .

KEY STATS

  • Open361.63
  • Day High366.96
  • Day Low348.77
  • Prev Close364.09
  • 52 Week High456.23
  • 52 Week High Date08/07/20
  • 52 Week Low182.07
  • 52 Week Low Date03/17/20
  • Market Cap33.861B
  • Shares Out96.18M
  • 10 Day Average Volume0.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.82
  • 1 Year % Change22.86

RATIOS/PROFITABILITY

  • EPS (TTM)4.99
  • P/E (TTM)70.53
  • Fwd P/E (NTM)147.24
  • EBITDA (MRQ)391.00M
  • ROE (MRQ)36.44%
  • Revenue (MRQ)1.927B
  • Gross Margin (MRQ)67.71%
  • Net Margin (MRQ)25.62%
  • Debt To Equity (MRQ)94.23%

EVENTS

  • Earnings Date04/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest DXCM News From Our Partners

QUOTE FINDER

Profile

MORE
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark)...
Kevin Sayer
Chairman
Quentin Blackford
Chief Financial Officer
Jake Leach
Executive Vice President
Andrew Balo
Executive Vice President
Patrick Murphy
Executive Vice President
Address
6340 Sequence Dr
San Diego, CA
92121-4356
United States